Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 -9.643M
March 31, 2026 -13.15M
December 31, 2025 20.09M
September 30, 2025 -7.703M
June 30, 2025 -17.97M
March 31, 2025 -13.80M
December 31, 2024 -16.47M
September 30, 2024 -12.98M
June 30, 2024 -12.17M
March 31, 2024 -7.789M
December 31, 2023 -11.04M
September 30, 2023 -16.30M
June 30, 2023 -16.09M
March 31, 2023 -9.212M
December 31, 2022 4.917M
September 30, 2022 19.73M
June 30, 2022 -2.181M
March 31, 2022 -11.19M
December 31, 2021 0.66M
September 30, 2021 -0.192M
June 30, 2021 -8.295M
March 31, 2021 -6.44M
December 31, 2020 -1.492M
September 30, 2020 -3.474M
June 30, 2020 -10.07M
Date Value
March 31, 2020 -1.425M
December 31, 2019 -3.661M
September 30, 2019 -0.99M
June 30, 2019 -5.058M
March 31, 2019 -2.851M
December 31, 2018 -0.72M
September 30, 2018 -1.233M
June 30, 2018 -7.956M
March 31, 2018 -4.185M
December 31, 2017 7.626M
September 30, 2017 -4.85M
June 30, 2017 -7.965M
March 31, 2017 -3.566M
December 31, 2016 4.28M
September 30, 2016 -6.327M
June 30, 2016 -0.032M
March 31, 2016 0.219M
December 31, 2015 5.236M
September 30, 2015 0.481M
June 30, 2015 -4.125M
March 31, 2015 -3.838M
December 31, 2014 4.974M
September 30, 2014 1.214M
June 30, 2014 -4.277M
March 31, 2014 -2.405M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Lifecore Biomedical, Inc. -2.189M
Quanterix Corp. -5.119M
Frontage Holdings Corp. --
Repligen Corp. 32.77M
Bio-Techne Corp. 95.42M